» Articles » PMID: 10631935

The Specificity of Proteasomes: Impact on MHC Class I Processing and Presentation of Antigens

Overview
Journal Immunol Rev
Date 2000 Jan 13
PMID 10631935
Citations 20
Authors
Affiliations
Soon will be listed here.
Abstract

We have studied polypeptide processing by purified proteasomes, with regard to proteolytic specificity and cytotoxic T-lymphocyte (CTL) epitope generation. Owing to defined preferences with respect to cleavage sites and fragment length, proteasomes degrade polypeptide substrates into cohorts of overlapping oligopeptides. Many of the proteolytic fragments exhibit structural features in common with major histocompatibility complex (MHC) class I ligands including fragment size and frequencies of amino acids at fragment boundaries. Proteasomes frequently generate definitive MHC class I ligands and/or slightly longer peptides, while substantially larger peptides are rare. Individual CTL epitopes are produced in widely varying amounts, often consistent with immunohierarchies among CTL epitopes. We further found that polypeptide processing is remarkably conserved among proteasomes of eukaryotic origin and that invertebrate proteasomes can efficiently produce known high-copy MHC class I ligands, suggesting evolutionary adaptation of the transporter associated with antigen processing and MHC class I to ancient constraints imposed by proteasomal protein degradation.

Citing Articles

In vitro proteasome processing of neo-splicetopes does not predict their presentation in vivo.

Willimsky G, Beier C, Immisch L, Papafotiou G, Scheuplein V, Goede A Elife. 2021; 10.

PMID: 33875134 PMC: 8154032. DOI: 10.7554/eLife.62019.


Immunoproteasome in the blood plasma of children with acute appendicitis, and its correlation with proteasome and UCHL1 measured by SPR imaging biosensors.

Matuszczak E, Sankiewicz A, Debek W, Gorodkiewicz E, Milewski R, Hermanowicz A Clin Exp Immunol. 2017; 191(1):125-132.

PMID: 28940383 PMC: 5721234. DOI: 10.1111/cei.13056.


Replication-Competent Foamy Virus Vaccine Vectors as Novel Epitope Scaffolds for Immunotherapy.

Lei J, Osen W, Gardyan A, Hotz-Wagenblatt A, Wei G, Gissmann L PLoS One. 2015; 10(9):e0138458.

PMID: 26397953 PMC: 4580568. DOI: 10.1371/journal.pone.0138458.


The immunoproteasome and viral infection: a complex regulator of inflammation.

McCarthy M, Weinberg J Front Microbiol. 2015; 6:21.

PMID: 25688236 PMC: 4310299. DOI: 10.3389/fmicb.2015.00021.


Similar intracellular peptide profile of TAP1/β2 microglobulin double-knockout mice and C57BL/6 wild-type mice as revealed by peptidomic analysis.

Castro L, Berti D, Russo L, Coelho V, Gozzo F, Oliveira V AAPS J. 2010; 12(4):608-16.

PMID: 20665142 PMC: 2977002. DOI: 10.1208/s12248-010-9224-y.